Skip to content
Sotera Health Co

Greenlight Capital Sotera Health Co transactions over time

SHC

Sotera Health Co historical holders

total: 1

Transactions details

Total transactions:
10
New positions:
2
Sold out:
1
Added:
4
Reduced:
3
Held for:
0 quarters
Latest activity:
2026 Q3
David Einhorn has been an institutional investor in Sotera Health Co (SHC) since 2023 Q2. According to 2026 Q3 report, David Einhorn holds 3,241,725 shares with a market value of roughly $59.94M representing 1.69% of their equity portfolio. The fund/company first acquired SHC in 2023 Q2, initially purchasing 5,450 shares. David Einhorn later completely sold out the position and reinvested in SHC again in 2025 Q2. Since the initial investment, Greenlight Capital has made 9 more transactions in this position.

Does David Einhorn still hold SHC?

Yes, David Einhorn continues to hold Sotera Health Co (SHC). According to their 2026 Q3 report, they maintain a position of 3,241,725 shares valued at approximately $59.94M, representing 1.69% of their equity portfolio.

When did David Einhorn first invest in SHC?

David Einhorn first invested in Sotera Health Co (SHC) in 2023 Q2 at the reported quarter-end price of $18.84 per share, acquiring 5,450 shares in their initial purchase.

Has David Einhorn reinvested in SHC after selling?

Yes, David Einhorn has shown renewed interest in Sotera Health Co (SHC). After completely selling their position, they reinitiated an investment in 2025 Q2, demonstrating continued conviction in this ticker.

SHC transactions history by Greenlight Capital

10 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q3
1.69%
3,241,725
$18.49
$59,939,496
-21.61% (-893,790)
-0.42%
2026 Q2
1.88%
4,135,515
$17.75
$73,405,392
+100.20% (+2,069,835)
+0.94%
2026 Q1
0.93%
2,065,680
$14.34
$29,621,851
+347.82% (+1,604,410)
+0.72%
2025 Q4
0.29%
461,270
$17.64
$8,136,803
+155.44% (+280,690)
+0.17%
2025 Q3
0.11%
180,580
$15.73
$2,840,524
-22.73% (-53,110)
-0.04%
2025 Q2
0.11%
233,690
$11.12
$2,598,632
new
+0.11%
2024 Q3
0.00%
0
$11.87
-100% (-300,110)
-0.17%
2024 Q1
0.16%
300,110
$12.01
$3,604,321
-10.94% (-36,860)
-0.02%
2023 Q3
0.29%
336,970
$14.98
$5,047,810
+6,082.94% (+331,520)
+0.28%
2023 Q2
0.00%
5,450
$18.84
$102,678
new
+0%
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.